Introduction to Market Access

For commercial and Medical Affairs professionals on the Danish market.

7. Sep 2021

1 day course

Danish

5,995 DKK ex VAT
(app. 806 EUR ex VAT)
50% DISCOUNT FOR PUBLIC INSTITUTIONS

Summary

Are you aware of how you can contribute to a successful Market Access effort? And do you know how your colleagues in Market Access support your work?

Successful Market Access work is essential for pharmaceutical companies to get products on the market. It requires a structured effort and contribution from the entire organisation. In this course, you gain an understanding of Market Access work, including the key external stakeholders, how you yourself can contribute to success, and how your Market Access colleagues can help you.

In order to be able to customise the course in the best possible way, we will send you a link before the course starts: We hope you will use it to send us 1-3 examples of typical issues/misunderstandings that you have experienced between you and your Market Access colleagues. Of course, your input will be 100% anonymous.

 

Key words

  • Danish market access
  • Health economy and clinical data
  • Pricing, reimbursement and negotiation
  • The Danish health care system
  • Internal stakeholder collaboration
  • Hands-on market access case work

Hi! Do you need help choosing the right course?

We are ready to help you at +45 39 27 60 60 or contact@atriumcph.com

Read more

Course leader(s) & Lecturers

  • Anne Kolbye
    Course leader
    Value Demonstration Manager
    Roche A/S
  • Thomas Bruun Kolbye
    Course leader
    Partner
    Carve Consulting
  • Sune Tüxen Jørgensen
    Lecturer
    Squad Lead
    Roche A/S
See all

IS THIS COURSE FOR YOU?

Employees in pharmaceutical companies working with sales, marketing, Medical Affairs and Regulatory Affairs for the Danish market.

What you will learn

  1. You will gain a deeper understanding of Market Access processes, the role of the health economics approach and key terms
  2. You obtain knowledge about key stakeholders in the Danish health care system such as the Danish Medicines Council, Amgros, the regional medicine councils, hospital management and head of hospital clinics, their focus and expectations towards pharma companies and consequences for Market Access work
  3. You gain insight into how knowledge from different departments in a company - and yourself as a colleague - can contribute to Market Access success in the Danish market
  4. You learn how your own work can benefit from help from your Market Access colleagues
  5. You follow a company's process towards getting a drug through a Medicines Council process
  6. You get an overview of the most important trends in the healthcare system and a discussion of how these trends affect the collaboration between public healthcare agencies and the pharmaceutical industry

What your company will get

  1. An employee who understands the processes of Market Access work and the most important external stakeholders in the Danish healthcare system
  2. An employee who knows how he or she can support Market Access colleagues with knowledge from his/her daily work and relationship with stakeholders

Course calendar

7. Sep 2021 9:00-16:00

DAY 1

  • Welcome and introduction to the day, including participants’ expectations
  • Goals, competencies and stakeholders in Market Access
  • Clinicians ‘and payers’ focus and view on collaboration with the pharmaceutical industry
  • Pricing and price negotiations
  • Case: The Danish Medicines Council process from the point of view of a pharmaceutical company - and your contribution as a colleague
  • Trends in the Danish healthcare system
  • Discussion and questions
Practical information

Registration

Registration deadline
31. Aug 2021
Atrium
Lersø Parkallé 101
2100 København Ø
Sometimes things change. This is the expected programme.

Course information

Literature

Before the course, you will have access to information about compulsory and voluntary reading material via your personal Atrium log-in.

Familiarise yourself with the compulsory reading material before the course, including the introductory parts of the Danish Medicines Council’s method manual for new medicines (approx. 10-15 pages), find it on their website: https://medicinraadet.dk/

Examination

There is no exam for this course.

Course leader(s)

Anne Kolbye
Value Demonstration Manager
Roche A/S
Thomas Bruun Kolbye
Partner
Carve Consulting

Lecturers

Anne Kolbye
Value Demonstration Manager
Roche A/S
Thomas Bruun Kolbye
Partner
Carve Consulting
Sune Tüxen Jørgensen
Squad Lead
Roche A/S

You may also be interested in these courses

Want to know more or need help?

Contact Client Manager Birger Flinthagen at +45 39 15 09 06

Send me a message